Tibet AIM Pharm. Inc. (SHE:002826)
China · Delayed Price · Currency is CNY 21.24
+0.26 (1.24%)
Feb 4, 2026, 3:04 PM CST
Tibet AIM Pharm. Revenue
Tibet AIM Pharm. had revenue of 177.54M CNY in the quarter ending September 30, 2025, with 10.37% growth. This brings the company's revenue in the last twelve months to 628.02M, down -2.11% year-over-year. In the year 2024, Tibet AIM Pharm. had annual revenue of 651.88M, down -2.27%.
Revenue (ttm)
628.02M
Revenue Growth
-2.11%
P/S Ratio
6.33
Revenue / Employee
1.56M
Employees
403
Market Cap
3.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 651.88M | -15.16M | -2.27% |
| Dec 31, 2023 | 667.04M | -189.70M | -22.14% |
| Jan 1, 2023 | 856.73M | 131.28M | 18.10% |
| Jan 1, 2022 | 725.46M | 122.84M | 20.38% |
| Dec 31, 2020 | 602.62M | 49.36M | 8.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition